488 related articles for article (PubMed ID: 11394728)
1. Oxcarbazepine, an antiepileptic agent.
Kalis MM; Huff NA
Clin Ther; 2001 May; 23(5):680-700; discussion 645. PubMed ID: 11394728
[TBL] [Abstract][Full Text] [Related]
2. Oxcarbazepine: a review of its use in children with epilepsy.
Bang L; Goa K
Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
[TBL] [Abstract][Full Text] [Related]
3. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
Wellington K; Goa KL
CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
[TBL] [Abstract][Full Text] [Related]
4. Spotlight on oxcarbazepine in epilepsy.
Bang LM; Goa KL
CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
6. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
Grant SM; Faulds D
Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
[TBL] [Abstract][Full Text] [Related]
8. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy.
Barcs G; Walker EB; Elger CE; Scaramelli A; Stefan H; Sturm Y; Moore A; Flesch G; Kramer L; D'Souza J
Epilepsia; 2000 Dec; 41(12):1597-607. PubMed ID: 11114219
[TBL] [Abstract][Full Text] [Related]
9. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial.
French JA; Baroldi P; Brittain ST; Johnson JK;
Acta Neurol Scand; 2014 Mar; 129(3):143-53. PubMed ID: 24359313
[TBL] [Abstract][Full Text] [Related]
11. Oxcarbazepine in the treatment of epilepsy.
Glauser TA
Pharmacotherapy; 2001 Aug; 21(8):904-19. PubMed ID: 11718497
[TBL] [Abstract][Full Text] [Related]
12. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
Muller M; Marson AG; Williamson PR
Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
[TBL] [Abstract][Full Text] [Related]
13. [Oxcarbazepine in the treatment of epilepsy. A review and update].
Horga de la Parte JF; Horga A
Rev Neurol; 2006 Jan 16-31; 42(2):95-113. PubMed ID: 16450324
[TBL] [Abstract][Full Text] [Related]
14. [Oxcarbazepine].
Arroyo S
Neurologia; 2001 Oct; 16(8):370-5. PubMed ID: 11738014
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine add-on for drug-resistant partial epilepsy.
Castillo S; Schmidt DB; White S
Cochrane Database Syst Rev; 2000; (3):CD002028. PubMed ID: 10908522
[TBL] [Abstract][Full Text] [Related]
16. Oxcarbazepine.
Tecoma ES
Epilepsia; 1999; 40 Suppl 5():S37-46. PubMed ID: 10530693
[TBL] [Abstract][Full Text] [Related]
17. Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine?
Houtkooper MA; Lammertsma A; Meyer JW; Goedhart DM; Meinardi H; van Oorschot CA; Blom GF; Höppener RJ; Hulsman JA
Epilepsia; 1987; 28(6):693-8. PubMed ID: 3319537
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of epilepsy: newly approved and developmental agents.
Stephen LJ; Brodie MJ
CNS Drugs; 2011 Feb; 25(2):89-107. PubMed ID: 21254787
[TBL] [Abstract][Full Text] [Related]
19. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
20. WITHDRAWN: Oxcarbazepine add-on for drug-resistant partial epilepsy.
Castillo SM; Schmidt DB; White S; Shukralla A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD002028. PubMed ID: 27845825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
